Clinical Scorecard: Crusted Erythrodermic Scabies: A Case Report Highlighting Diagnostic Challenges and a Brief Review
At a Glance
Category
Detail
Condition
Crusted Scabies
Key Mechanisms
Caused by Sarcoptes scabiei var. hominis, characterized by intense pruritus and hyperkeratotic lesions due to mite proliferation and altered immune response.
Target Population
Elderly individuals and those with multiple comorbidities.
Care Setting
Primary care and general practice settings.
Key Highlights
Crusted scabies accounts for <0.5% of erythroderma cases.
Diagnostic challenges arise due to clinical overlap with other dermatoses.
Skin biopsy may show psoriasiform changes without detectable mites.
Treatment with oral ivermectin and topical therapy can lead to marked improvement.
Misdiagnosis can lead to inappropriate immunosuppressive therapy.
Guideline-Based Recommendations
Diagnosis
Consider crusted scabies in patients with erythroderma and pruritus.
Utilize skin scrapings for parasitological examination.
Management
Administer targeted antiparasitic therapy rather than immunosuppression.
Monitoring & Follow-up
Monitor for complications such as sepsis and metabolic disturbances.
Risks
Increased risk of life-threatening complications in frail individuals.
Patient & Prescribing Data
Elderly patients with a history of inflammatory skin conditions.
Oral ivermectin and topical scabicidal therapy are effective.
Clinical Best Practices
Integrate clinical assessment with parasitological examination.
Educate healthcare providers on the manifestations of scabies.
A randomized clinical trial found that a team-based connected health model achieved equivalent improvements in atopic dermatitis severity and symptoms compared with conventional in-person care over 12 months.
